H-L-Thr-OBzl*oxalate

H-L-Thr-OBzl*oxalate is a protected threonine derivative in which the amino acid is present as the L-stereoisomer with a benzyl ester functionality on the carboxylate and an oxalate counterion/association that supports isolable handling. The threonine side chain contains a β-hydroxyl group, enabling selective derivatization to access O-acylated or O-alkylated variants while maintaining compatibility with peptide coupling chemistries. The benzylic ester form participates in orthogonal protection strategies, since benzyl esters can be removed under hydrogenolysis conditions to reveal the free carboxylic acid for downstream amide bond formation. The chiral center at the α-carbon and the stereodefined β-hydroxyl-bearing side chain make the compound suitable for stereochemically controlled amino acid ester synthesis and for preparing peptide building blocks or biochemical research intermediates.

1. Peptide Synthesis

H-L-Thr-OBzl*oxalate is applied in peptide building block preparation where the benzyl-protected carboxyl group can be converted into an activated coupling partner after ester deprotection or functional group transformation. The L-threonine backbone provides the α-amino functionality for incorporation into linear peptides, while the side-chain hydroxyl can be managed through selective protection or later functionalization to control chemoselectivity during peptide assembly. The oxalate association can improve handling of the amino acid ester intermediate, supporting reproducible feedstock preparation for solid-phase or solution-phase peptide coupling workflows. The resulting threonine-containing peptide fragments enable construction of peptide libraries and sequence-defined analogs used in structure-activity relationship studies and peptide science.

2. Side-Chain Functionalization

H-L-Thr-OBzl*oxalate is suitable for side-chain functionalization programs targeting the β-hydroxyl group of threonine to generate O-derivatized variants such as O-acyl, O-alkyl, or O-linked conjugation handles. The presence of a protected carboxylate as a benzyl ester helps maintain the amino acid skeleton during hydroxyl-specific transformations, enabling orthogonal manipulation of the side chain without premature interference from carboxyl reactivity. The stereodefined threonine framework supports the synthesis of stereochemically consistent O-functionalized amino acid derivatives that can be carried forward into peptide analogs or small-molecule scaffolds. Downstream utility includes preparing functionalized threonine residues for biochemical probes, peptidomimetic construction, and conjugation-ready intermediates.

3. Chiral Amino Acid Intermediate

H-L-Thr-OBzl*oxalate serves as a chiral amino acid intermediate for stereoselective synthesis routes that require L-threonine configuration to be preserved through multiple protection and deprotection steps. The α-chiral center and the β-hydroxyl-bearing side chain provide a defined three-dimensional motif that can influence amide bond geometry and conformational preferences in peptides and peptidomimetics. The benzyl ester protecting group supports staged synthesis, since carboxyl activation can be deferred until the desired synthetic stage while the side chain remains available for controlled derivatization. The oxalate-associated form can be leveraged for consistent intermediate handling in fine chemical synthesis and for producing downstream protected amino acid derivatives used in chiral building block development.

4. Chemical Biology Probes

H-L-Thr-OBzl*oxalate is utilized in chemical biology research to generate threonine-containing fragments for labeling, affinity probes, and mechanistic studies of peptide recognition. The side-chain hydroxyl enables incorporation of functional tags through O-derivatization, supporting probe designs that include hydroxyl-reactive handles or linkers for conjugation to biomolecular targets. The benzyl ester protection strategy allows the compound to be carried through scaffold assembly while minimizing undesired carboxyl participation during probe synthesis. The stereodefined threonine residue can be embedded into peptide-like constructs to probe binding preferences, enabling downstream formation of labeled analogs for analytical research and molecular recognition studies.

5. Pharmaceutical Intermediate Preparation

H-L-Thr-OBzl*oxalate is relevant to pharmaceutical intermediate preparation where threonine-derived building blocks are required for peptide-based or peptidomimetic synthesis. The protected carboxylate and amino functionality support controlled conversion into coupling-ready forms, enabling manufacturing route design that separates protection management from later amide bond formation steps. The β-hydroxyl group can be preserved or transformed to match the functional-group requirements of target scaffolds, including compatibility with protecting-group strategies used in industrial peptide chemistry. The compound's defined stereochemistry supports consistent batch-to-batch construction of threonine-containing fragments used as intermediates in fine chemical synthesis and specialty chemical production.

6. Process Chemistry Intermediate

H-L-Thr-OBzl*oxalate can be employed as a process chemistry intermediate for scalable amino acid ester handling and for route development that emphasizes orthogonal functional group control. The benzyl ester protecting group provides a stable carboxyl masking strategy during upstream operations, while the oxalate association supports isolable intermediate preparation that can fit into staged manufacturing workflows. The stereodefined L-threonine structure and the β-hydroxyl functionality enable predictable downstream transformations into activated carboxylic acid forms and side-chain-modified derivatives. The resulting threonine-based intermediates can feed into larger synthetic sequences for peptide building block preparation, peptidomimetic construction, and industrial chemical manufacturing where controlled protection/deprotection logic is required.

1. TMEM16F and dynamins control expansive plasma membrane reservoirs

2. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

3. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

4. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

5. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line